Tuesday March 26th, 2019 62% of drug shortage can be solved with parallel imports
Tuesday March 26th, 2019

European statistics show that parallel distributors react as quickly as possible in such cases and can overcome the deficit on average for 3 weeks. The association develops a patient platform that directly alerts drug shortage by patients.

Tuesday March 19th, 2019 BAMPTD works in favor of patients, seeking real solutions and countering the myths about parallel distribution
Tuesday March 19th, 2019

How parallel imports can provide deficiency drugs and what are the myths about parallel exports were the main topics that were discussed between the transplanted and dialysis patients and the executive director of BAMPTD Boryana Marinkova.

Tuesday March 19th, 2019 Over 1500 medicines have been deregistered
Tuesday March 19th, 2019

They are stopped by the expensive registration mode and in 2017 alone they are 15% more than new ones. In just 4 years – from 2014 to 2018, 1512 drugs have been withdrawn from the Bulgarian market, BDA report shows. Of these, 327 are no longer available in the country, with no drug being withdrawn …

Tuesday March 19th, 2019 1512 medicines have been deregistered from Bulgarian market for 4 years
Tuesday March 19th, 2019

(български) В 62% от случаите причините за недостиг на лекарства касаят временно или трайно преустановен внос на лекарства и т.нар. “дерегистрирани лекарства”, чиито досиета са изтрити от България по желание на техните първовносители. „И които лекарите продължават да изписват и пациентите продължават да търсят, без те да са налични на нашата територия“, обясни пред „Хоризонт“ Боряна Маринкова, председател на Асоциацията за развитие на паралелната търговия с лекарства.

Thursday January 24th, 2019 The role of parallel distributors in the verification process is very important and is in favor of patients
Thursday January 24th, 2019

The role of parallel distributors in the verification process is very important and is in favor of patients. This was announced by Hristofor Ivanov, Chairman of the BAMPTD Management Board, who participated in a media training dedicated to the forthcoming enforcement of the largest public-private project in the EU.

Wednesday January 16th, 2019 The drugs that left Bulgaria
Wednesday January 16th, 2019

A total of 1512 medicines are deregistered by their manufacturers and are no longer sold in Bulgaria between 2014 and 2017, according to data from the Bulgarian Drug Agency. The number is impressive in the context of the total number of about 6000 prescription or non-prescription registered medicines.  Data for 2018 is not yet ready, but in 2017 those discontinued by marketing authorizations are 327, while those who have renewed them are 273.

Thursday January 10th, 2019 Deregistered medicines to be subject to parallel imports, BAMPTD insists
Thursday January 10th, 2019

Three proposals in the Law on Medicinal Products for Human Medicine and for amending the Ordinance on Regulation and Registration of Medicines Prices were submitted by the Bulgarian Association for the Medicines Parallel Trade Development of  (BAMPTD) to the Ministry of Health and the National Assembly. This was announced by Boryana Marinkova, Executive Director of BAMPTD to Zdrave.net.

Thursday December 27th, 2018 Parallel imports verification has the highest safety guarantee
Thursday December 27th, 2018

In parallel distribution drug verification has the highest degree of guarantee of origin of medicines, due to the fact they undergo a double check to authenticate them. In the case of parallel imports and exports, the safety of the patients is guaranteed to the maximum, because they also determine whether the contents correspond to what is written on the package of the medicine.

Sunday November 25th, 2018 The process of serialization and verification has been successfully implemented by BestaMed
Sunday November 25th, 2018

Now that BestaMed have achieved serialization, pharmacists and patients can now be assured that BestaMed serialized medicines are of the highest quality and meet the all aspects of the Falsified Medicines Directive.

Sunday November 25th, 2018 Parallel imports in Bulgaria are lagging behind regulatory obstacles
Sunday November 25th, 2018

Shortage of medicines is a global problem and a hot topic in the European Union. Its causes are multifactorial and exports are not among the leading ones. We have repeatedly cited global and European reports that are clear that production problems and regulations take a major lead. Evidence that parallel distribution does not generate any gaps is a shortage in countries like the United States or Serbia, where parallel trade is not taking place.